The global Flu Vaccine market is projected to reach US$ 7673.2 million by 2030 from an estimated US$ 5791.7 million in 2024, at a CAGR of 4.8% during 2024 and 2030.

Flu Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Flu Vaccine.

The Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flu Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Flu Vaccine Market Report

Report Metric	Details
Report Name	Flu Vaccine Market
Accounted market size in 2024	an estimated US$ 5791.7 million
Forecasted market size in 2030	US$ 7673.2 million
CAGR	4.8%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Trivalent Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Flu Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Flu Vaccine Market growing?

Ans: The Flu Vaccine Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Flu Vaccine Market size in 2030?

Ans: The Flu Vaccine Market size in 2030 will be US$ 7673.2 million.

What is the market share of major companies in Flu Vaccine Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Flu Vaccine Market share by type?

Ans: In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%.

Who are the main players in the Flu Vaccine Market report?

Ans: The main players in the Flu Vaccine Market are Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO

What are the Application segmentation covered in the Flu Vaccine Market report?

Ans: The Applications covered in the Flu Vaccine Market report are For Children (6 months to 3 years), For Adults and Children over 3 years

What are the Type segmentation covered in the Flu Vaccine Market report?

Ans: The Types covered in the Flu Vaccine Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Study Coverage

1.1 Flu Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Flu Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Market by Application

1.3.1 Global Flu Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Flu Vaccine Market Size Estimates and Forecasts

2.1.1 Global Flu Vaccine Revenue 2019-2030

2.1.2 Global Flu Vaccine Sales 2019-2030

2.2 Flu Vaccine Market Size by Region: 2023 Versus 2030

2.3 Flu Vaccine Sales by Region (2019-2030)

2.3.1 Global Flu Vaccine Sales by Region: 2019-2024

2.3.2 Global Flu Vaccine Sales Forecast by Region (2025-2030)

2.3.3 Global Flu Vaccine Sales Market Share by Region (2019-2030)

2.4 Flu Vaccine Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Flu Vaccine Revenue by Region: 2019-2024

2.4.2 Global Flu Vaccine Revenue Forecast by Region (2025-2030)

2.4.3 Global Flu Vaccine Revenue Market Share by Region (2019-2030)

3 Global Flu Vaccine by Manufacturers

3.1 Global Top Flu Vaccine Manufacturers by Sales

3.1.1 Global Flu Vaccine Sales by Manufacturer (2019-2024)

3.1.2 Global Flu Vaccine Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Flu Vaccine Manufacturers by Revenue

3.2.1 Global Flu Vaccine Revenue by Manufacturer (2019-2024)

3.2.2 Global Flu Vaccine Revenue Share by Manufacturer (2019-2024)

3.3 Global Flu Vaccine Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Flu Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global Flu Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Flu Vaccine Manufacturing Base Distribution, Product Type

3.5.1 Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Flu Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into Flu Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Sanofi Pasteur

4.1.1 Sanofi Pasteur Company Information

4.1.2 Sanofi Pasteur Description, Business Overview

4.1.3 Sanofi Pasteur Flu Vaccine Products Offered

4.1.4 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.1.5 Sanofi Pasteur Flu Vaccine Sales by Product in 2023

4.1.6 Sanofi Pasteur Flu Vaccine Sales by Application in 2023

4.1.7 Sanofi Pasteur Flu Vaccine Sales by Geographic Area in 2023

4.1.8 Sanofi Pasteur Recent Developments

4.2 CSL

4.2.1 CSL Company Information

4.2.2 CSL Description, Business Overview

4.2.3 CSL Flu Vaccine Products Offered

4.2.4 CSL Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.2.5 CSL Flu Vaccine Sales by Product in 2023

4.2.6 CSL Flu Vaccine Sales by Application in 2023

4.2.7 CSL Flu Vaccine Sales by Geographic Area in 2023

4.2.8 CSL Recent Developments

4.3 GSK

4.3.1 GSK Company Information

4.3.2 GSK Description, Business Overview

4.3.3 GSK Flu Vaccine Products Offered

4.3.4 GSK Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.3.5 GSK Flu Vaccine Sales by Product in 2023

4.3.6 GSK Flu Vaccine Sales by Application in 2023

4.3.7 GSK Flu Vaccine Sales by Geographic Area in 2023

4.3.8 GSK Recent Developments

4.4 Mylan

4.4.1 Mylan Company Information

4.4.2 Mylan Description, Business Overview

4.4.3 Mylan Flu Vaccine Products Offered

4.4.4 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Mylan Flu Vaccine Sales by Product in 2023

4.4.6 Mylan Flu Vaccine Sales by Application in 2023

4.4.7 Mylan Flu Vaccine Sales by Geographic Area in 2023

4.4.8 Mylan Recent Developments

4.5 Hulan Bio

4.5.1 Hulan Bio Company Information

4.5.2 Hulan Bio Description, Business Overview

4.5.3 Hulan Bio Flu Vaccine Products Offered

4.5.4 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Hulan Bio Flu Vaccine Sales by Product in 2023

4.5.6 Hulan Bio Flu Vaccine Sales by Application in 2023

4.5.7 Hulan Bio Flu Vaccine Sales by Geographic Area in 2023

4.5.8 Hulan Bio Recent Developments

4.6 AstraZeneca

4.6.1 AstraZeneca Company Information

4.6.2 AstraZeneca Description, Business Overview

4.6.3 AstraZeneca Flu Vaccine Products Offered

4.6.4 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.6.5 AstraZeneca Flu Vaccine Sales by Product in 2023

4.6.6 AstraZeneca Flu Vaccine Sales by Application in 2023

4.6.7 AstraZeneca Flu Vaccine Sales by Geographic Area in 2023

4.6.8 AstraZeneca Recent Development

4.7 CCBIO

4.7.1 CCBIO Company Information

4.7.2 CCBIO Description, Business Overview

4.7.3 CCBIO Flu Vaccine Products Offered

4.7.4 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.7.5 CCBIO Flu Vaccine Sales by Product in 2023

4.7.6 CCBIO Flu Vaccine Sales by Application in 2023

4.7.7 CCBIO Flu Vaccine Sales by Geographic Area in 2023

4.7.8 CCBIO Recent Development

5 Breakdown Data by Type

5.1 Global Flu Vaccine Sales by Type (2019-2030)

5.1.1 Global Flu Vaccine Sales by Type (2019-2024)

5.1.2 Global Flu Vaccine Sales Forecast by Type (2025-2030)

5.1.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)

5.2 Global Flu Vaccine Revenue Forecast by Type (2019-2030)

5.2.1 Global Flu Vaccine Revenue by Type (2019-2024)

5.2.2 Global Flu Vaccine Revenue Forecast by Type (2025-2030)

5.2.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)

5.3 Flu Vaccine Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Flu Vaccine Sales by Application (2019-2030)

6.1.1 Global Flu Vaccine Sales by Application (2019-2024)

6.1.2 Global Flu Vaccine Sales Forecast by Application (2025-2030)

6.1.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)

6.2 Global Flu Vaccine Revenue Forecast by Application (2019-2030)

6.2.1 Global Flu Vaccine Revenue by Application (2019-2024)

6.2.2 Global Flu Vaccine Revenue Forecast by Application (2025-2030)

6.2.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)

6.3 Flu Vaccine Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Flu Vaccine Market Size YoY Growth 2019-2030

7.2 North America Flu Vaccine Market Facts & Figures by Country

7.2.1 North America Flu Vaccine Sales by Country (2019-2030)

7.2.2 North America Flu Vaccine Revenue by Country (2019-2030)

7.3 North America Flu Vaccine Sales by Type (2019-2024)

7.4 North America Flu Vaccine Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Flu Vaccine Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Flu Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific Flu Vaccine Sales by Region (2019-2030)

8.2.2 Asia-Pacific Flu Vaccine Revenue by Region (2019-2030)

8.3 Asia-Pacific Flu Vaccine Sales by Type (2019-2024)

8.4 Asia-Pacific Flu Vaccine Sales by Application (2019-2024)

9 Europe

9.1 Europe Flu Vaccine Market Size YoY Growth 2019-2030

9.2 Europe Flu Vaccine Market Facts & Figures by Country

9.2.1 Europe Flu Vaccine Sales by Country (2019-2030)

9.2.2 Europe Flu Vaccine Revenue by Country (2019-2030)

9.3 Europe Flu Vaccine Sales by Type (2019-2024)

9.4 Europe Flu Vaccine Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Flu Vaccine Market Size YoY Growth 2019-2030

10.2 Latin America Flu Vaccine Market Facts & Figures by Country

10.2.1 Latin America Flu Vaccine Sales by Country (2019-2030)

10.2.2 Latin America Flu Vaccine Revenue by Country (2019-2030)

10.3 Latin America Flu Vaccine Sales by Type (2019-2024)

10.4 Latin America Flu Vaccine Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Flu Vaccine Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Flu Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Flu Vaccine Sales by Country (2019-2030)

11.2.2 Middle East and Africa Flu Vaccine Revenue by Country (2019-2030)

11.3 Middle East and Africa Flu Vaccine Sales by Type (2019-2024)

11.4 Middle East and Africa Flu Vaccine Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Flu Vaccine Supply Chain Analysis

12.2 Flu Vaccine Key Raw Materials and Upstream Suppliers

12.3 Flu Vaccine Clients Analysis

12.4 Flu Vaccine Sales Channel and Sales Model Analysis

12.4.1 Flu Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Flu Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Flu Vaccine Distributors

13 Market Dynamics

13.1 Flu Vaccine Industry Trends

13.2 Flu Vaccine Market Drivers

13.3 Flu Vaccine Market Challenges

13.4 Flu Vaccine Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Flu Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Trivalent Influenza Vaccine

Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine

Table 4. Global Flu Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Flu Vaccine Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Flu Vaccine Sales by Region (2019-2024) & (M Doses)

Table 7. Global Flu Vaccine Sales Forecast by Region (2025-2030) & (M Doses)

Table 8. Global Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Flu Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Flu Vaccine Sales by Manufacturer (2019-2024) & (M Doses)

Table 11. Global Flu Vaccine Sales Share by Manufacturer (2019-2024)

Table 12. Flu Vaccine Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Flu Vaccine Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Flu Vaccine Price (2019-2024) & (US$/Dose)

Table 15. Ranking of Global Top Flu Vaccine Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Vaccine as of 2023)

Table 18. Flu Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Flu Vaccine Product Type

Table 20. Date of International Manufacturers Enter into Flu Vaccine Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Sanofi Pasteur Company Information

Table 23. Sanofi Pasteur Description and Business Overview

Table 24. Sanofi Pasteur Flu Vaccine Product

Table 25. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 26. Sanofi Pasteur Sales Proportion of Flu Vaccine by Product in 2023

Table 27. Sanofi Pasteur Sales Proportion of Flu Vaccine by Application in 2023

Table 28. Sanofi Pasteur Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 29. Sanofi Pasteur Recent Development

Table 30. CSL Company Information

Table 31. CSL Description and Business Overview

Table 32. CSL Flu Vaccine Product

Table 33. CSL Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 34. CSL Sales Proportion of Flu Vaccine by Product in 2023

Table 35. CSL Sales Proportion of Flu Vaccine by Application in 2023

Table 36. CSL Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 37. CSL Recent Development

Table 38. GSK Company Information

Table 39. GSK Description and Business Overview

Table 40. GSK Flu Vaccine Product

Table 41. GSK Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 42. GSK Sales Proportion of Flu Vaccine by Product in 2023

Table 43. GSK Sales Proportion of Flu Vaccine by Application in 2023

Table 44. GSK Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 45. GSK Recent Development

Table 46. Mylan Company Information

Table 47. Mylan Description and Business Overview

Table 48. Mylan Flu Vaccine Product

Table 49. Mylan Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 50. Mylan Sales Proportion of Flu Vaccine by Product in 2023

Table 51. Mylan Sales Proportion of Flu Vaccine by Application in 2023

Table 52. Mylan Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 53. Mylan Recent Development

Table 54. Hulan Bio Company Information

Table 55. Hulan Bio Description and Business Overview

Table 56. Hulan Bio Flu Vaccine Product

Table 57. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 58. Hulan Bio Sales Proportion of Flu Vaccine by Product in 2023

Table 59. Hulan Bio Sales Proportion of Flu Vaccine by Application in 2023

Table 60. Hulan Bio Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 61. Hulan Bio Recent Development

Table 62. AstraZeneca Company Information

Table 63. AstraZeneca Description and Business Overview

Table 64. AstraZeneca Flu Vaccine Product

Table 65. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 66. AstraZeneca Sales Proportion of Flu Vaccine by Product in 2023

Table 67. AstraZeneca Sales Proportion of Flu Vaccine by Application in 2023

Table 68. AstraZeneca Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 69. AstraZeneca Recent Development

Table 70. CCBIO Company Information

Table 71. CCBIO Description and Business Overview

Table 72. CCBIO Flu Vaccine Product

Table 73. CCBIO Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 74. CCBIO Sales Proportion of Flu Vaccine by Product in 2023

Table 75. CCBIO Sales Proportion of Flu Vaccine by Application in 2023

Table 76. CCBIO Sales Proportion of Flu Vaccine by Geographic Area in 2023

Table 77. CCBIO Recent Development

Table 78. Global Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 79. Global Flu Vaccine Sales Forecast by Type (2025-2030) & (M Doses)

Table 80. Global Flu Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 81. Global Flu Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 82. Global Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 83. Global Flu Vaccine Sales Forecast by Application (2025-2030) & (M Doses)

Table 84. Global Flu Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 85. Global Flu Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 86. North America Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 87. North America Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 88. North America Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 89. North America Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 90. North America Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 91. North America Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 92. Asia-Pacific Flu Vaccine Sales by Region (2019-2024) & (M Doses)

Table 93. Asia-Pacific Flu Vaccine Sales by Region (2025-2030) & (M Doses)

Table 94. Asia-Pacific Flu Vaccine Revenue by Region (2019-2030) & (US$ Million)

Table 95. Asia-Pacific Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 96. Asia-Pacific Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 97. Asia-Pacific Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 98. Europe Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 99. Europe Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 100. Europe Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 101. Europe Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 102. Europe Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 103. Europe Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 104. Latin America Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 105. Latin America Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 106. Latin America Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 107. Latin America Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 108. Latin America Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 109. Latin America Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 110. Middle East and Africa Flu Vaccine Sales by Country (2019-2024) & (M Doses)

Table 111. Middle East and Africa Flu Vaccine Sales by Country (2025-2030) & (M Doses)

Table 112. Middle East and Africa Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 113. Middle East and Africa Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 114. Middle East and Africa Flu Vaccine Sales by Type (2019-2024) & (M Doses)

Table 115. Middle East and Africa Flu Vaccine Sales by Application (2019-2024) & (M Doses)

Table 116. Flu Vaccine Key Raw Materials, Industry Status and Trend

Table 117. Flu Vaccine Key Raw Materials and Upstream Suppliers

Table 118. Flu Vaccine Clients Status and Trend

Table 119. Flu Vaccine Typical Clients

Table 120. Flu Vaccine Distributors

Table 121. Flu Vaccine Market Trends

Table 122. Flu Vaccine Market Drivers

Table 123. Flu Vaccine Market Challenges

Table 124. Flu Vaccine Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Flu Vaccine Product Picture

Figure 2. Global Flu Vaccine Sales Market Share by Type in 2023 & 2030

Figure 3. Trivalent Influenza Vaccine Product Picture

Figure 4. Quadrivalent Influenza Vaccine Product Picture

Figure 5. Global Flu Vaccine Sales Market Share by Application in 2023 & 2030

Figure 6. For Children (6 months to 3 years) Examples

Figure 7. For Adults and Children over 3 years Examples

Figure 8. Flu Vaccine Report Years Considered

Figure 9. Global Flu Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Flu Vaccine Market Size 2019-2030 (US$ Million)

Figure 11. Global Flu Vaccine Sales 2019-2030 (M Doses)

Figure 12. Global Flu Vaccine Sales Market Share Forecast by Region (2019-2030)

Figure 13. Global Flu Vaccine Revenue Market Share by Region (2019-2030)

Figure 14. Global Flu Vaccine Sales Share by Manufacturer in 2023

Figure 15. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 16. Global Flu Vaccine Sales Market Share Forecast by Type (2019-2030)

Figure 17. Global Flu Vaccine Revenue Market Share Forecast by Type (2019-2030)

Figure 18. Flu Vaccine Average Selling Price (ASP) by Type (2019-2024) & (US$/Dose)

Figure 19. Global Flu Vaccine Sales Market Share Forecast by Application (2019-2030)

Figure 20. Global Flu Vaccine Revenue Market Share Forecast by Application (2019-2030)

Figure 21. Flu Vaccine Average Selling Price (ASP) by Application (2019-2024) & (US$/Dose)

Figure 22. North America Flu Vaccine Revenue 2019-2030 (US$ Million)

Figure 23. North America Flu Vaccine Sales Market Share by Type (2019-2024)

Figure 24. North America Flu Vaccine Sales Market Share by Application (2019-2024)

Figure 25. Asia-Pacific Flu Vaccine Revenue 2019-2030 (US$ Million)

Figure 26. Asia-Pacific Flu Vaccine Sales Market Share by Region (2019-2030)

Figure 27. Asia-Pacific Flu Vaccine Revenue Market Share by Region (2019-2030)

Figure 28. Asia-Pacific Flu Vaccine Sales Market Share by Type (2019-2024)

Figure 29. Asia-Pacific Flu Vaccine Sales Market Share by Application (2019-2024)

Figure 30. Europe Flu Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 31. Europe Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 32. Europe Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 33. Europe Flu Vaccine Sales Market Share by Type (2019-2024)

Figure 34. Europe Flu Vaccine Sales Market Share by Application (2019-2024)

Figure 35. Latin America Flu Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 36. Latin America Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 37. Latin America Flu Vaccine Revenue Market Share by Country (2019-2024)

Figure 38. Latin America Flu Vaccine Sales Market Share by Type (2019-2024)

Figure 39. Latin America Flu Vaccine Sales Market Share by Application (2019-2024)

Figure 40. Middle East and Africa Flu Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 41. Middle East and Africa Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 42. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 43. Middle East and Africa Flu Vaccine Sales Market Share by Type (2019-2024)

Figure 44. Middle East and Africa Flu Vaccine Sales Market Share by Application (2019-2024)

Figure 45. Flu Vaccine Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Flu Vaccine Raw Materials by Region in 2023

Figure 47. Flu Vaccine Distribution Channels

Figure 48. Global Flu Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 49. Global Flu Vaccine Percentage 2019-2030: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions